MDL® offers DiscoveryGate research platform to academia
Premier chemical information resource opened to students and faculty at institutions worldwide.
San Leandro, CA— March 29, 2004 — MDL Information Systems, Inc. (MDL®), an Elsevier company, has announced availability of its premier Web-based research platform to the academic community. DiscoveryGate, the structure-searchable resource for scientific information that has become a first stop for corporate scientists, is now open to students, faculty, and academic researchers worldwide.
“MDL is proud to make this resource available and affordable to the academic community,” said MDL CEO Bernard Aleva. “DiscoveryGate is unparalleled in its delivery of integrated, indexed content from Elsevier and MDL and other content providers including Thomson Derwent, Prous, FIZ Chemie, Springer, and Wiley.”
Academic researchers can now access 14 databases such as CrossFire Beilstein, MDL® Available Chemicals Directory, MDL® Drug Data Report, and MDL® Toxicity, authoritative reference works, and links to over 20,000 journal titles (additional licenses required to access third-party content in their environments).
DiscoveryGate does not merely provide author abstracts and indexed text records, but richly-excerpted information from the areas of chemistry, synthesis, ADME, toxicology, and pharmacology. With DiscoveryGate’s integration and linking of content, researchers can quickly compare results and information not available through other systems. DiscoveryGate gives researchers access to more than 13 million chemical structures, 10 million reactions, and over 200 million associated calculated and reported properties, including synthesis, bioactivity, metabolism, toxicology, and physical property data.
DiscoveryGate for academia ( gateway.discoverygate.com) features a campus-wide access model: When an institution licenses DiscoveryGate, any number of eligible faculty members, students, or researchers at the institution may simultaneously use it—access is not limited to a few people at a time.
“This is a tremendous boost for librarians, chemistry students, and faculty researchers,” said Tim Hoctor, product manager for MDL. “The system is affordable for institutions, management is simple, and availability to researchers is assured.”
With the new DiscoveryGate offering to academia, researchers can access structures and data with a simple query, perform structure-based clustering of results sets, quickly acquire a summary view of relevant data, and easily generate standardized reports. For an interactive tour of DiscoveryGate visit www.discoverygate.com.
MDL is a wholly owned subsidiary of Elsevier and its products and services are part of Elsevier’s life sciences portfolio. This portfolio combines extensive MDL informatics, database, workflow, and decision support solutions with Elsevier’s 400 chemistry and life science journals and related products—accelerating the discovery and development of innovative and successful new drugs by improving the speed and quality of scientists’ decision making.
Elsevier is a global information analytics business that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com
MDL Information Systems, Inc.
(510) 895-1313 ext. 1371